Nexo Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Nexo Therapeutics is a biotechnology company focused on discovering and developing new small molecule therapies for cancer patients who have limited treatment options. It combines covalent ligand discovery with chemical biology and applies its expertise in cancer biology and medicinal chemistry to pursue cancer drivers with novel approaches, supported by facilities in Watertown, Massachusetts, and Golden, Colorado, and led by founder and CEO Andrew Phillips, PhD.

Its target customers are cancer patients with unmet therapeutic needs and stakeholders in the oncology research community seeking new treatment options. The company operates within the biotechnology research industry, emphasizing mechanism-based drug discovery for oncology. In May 2026, Calico Life Sciences and Nexo announced a multi-target collaboration to discover and develop small molecule therapeutics for challenging disease targets.

Get verified Nexo Therapeutics emails free

Company overview Employee directory